These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7713278)

  • 1. Variability of blood glucose levels in patients with type 1 diabetes mellitus on intensified insulin regimens.
    Moberg EA; Lins PE; Adamson UK
    Diabete Metab; 1994; 20(6):546-52. PubMed ID: 7713278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-glucose self-monitoring in insulin treated type 2 diabetes mellitus a cross-sectional study with an intervention group.
    Schiel R; Müller UA; Rauchfub J; Sprott H; Müller R
    Diabetes Metab; 1999 Sep; 25(4):334-40. PubMed ID: 10566123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria.
    Schütt M; Kern W; Krause U; Busch P; Dapp A; Grziwotz R; Mayer I; Rosenbauer J; Wagner C; Zimmermann A; Kerner W; Holl RW;
    Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):384-8. PubMed ID: 16915542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
    Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
    Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. InDuo, a novel combined insulin injection and blood glucose monitoring device - effective and save as other devices, and patient preference.
    Haupt A; Berg B; Paschen P; Dreyer M; Häring HU; Smedegaard J; Skovlund SE; Matthaei S
    Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):541-4. PubMed ID: 16235158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two intensified conventional insulin regimens with three and four daily injections.
    Faglia E; Favales F; Brivio M; Calia P; Quarantiello A
    Diabete Metab; 1993; 19(6):575-81. PubMed ID: 8026609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of glycaemic variability in CSII vs. MDI treated type 1 diabetic patients using CGMS.
    Simon B; Treat V; Marco C; Rosenberg D; Joseph J; Hipszer B; Li Y; Chervoneva I; Padron-Massara L; Jabbour S
    Int J Clin Pract; 2008 Dec; 62(12):1858-63. PubMed ID: 19166434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
    Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes--results of the randomized, controlled PREDICTIVE 303 study.
    Meneghini L; Koenen C; Weng W; Selam JL
    Diabetes Obes Metab; 2007 Nov; 9(6):902-13. PubMed ID: 17924873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sources of glucose variability in insulin-treated type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).
    Murata GH; Duckworth WC; Shah JH; Wendel CS; Hoffman RM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):451-6. PubMed ID: 15049959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A within patient cross over trial of 4 insulin regimens in antibody-negative, C-peptide negative patients.
    Oswald GA; Yudkin JS
    Diabetes Res; 1987 Feb; 4(2):85-9. PubMed ID: 3555956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
    Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
    Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart.
    Ashwell SG; Gebbie J; Home PD
    Diabet Med; 2006 Aug; 23(8):879-86. PubMed ID: 16911626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of acarbose on postprandial increase in blood glucose. Additive acute effect of once daily administration in insulin treated diabetes].
    Ledermann H; Höxter G
    Fortschr Med; 1994 Nov; 112(32):467-70. PubMed ID: 7821886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nocturnal blood glucose profiles in patients with type 1 diabetes mellitus on multiple (> or = 4) daily insulin injection regimens.
    Vervoort G; Goldschmidt HM; van Doorn LG
    Diabet Med; 1996 Sep; 13(9):794-9. PubMed ID: 8891454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of various methods of intensive insulin therapy in hospital condition assessed by hypoglycaemic episodes detected with the use of continuous glucose monitoring system.
    Mozdzan M; Ruxer J; Loba J; Siejka A; Markuszewski L
    Adv Med Sci; 2006; 51():133-6. PubMed ID: 17357293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does an insulin pen improve the metabolic control of type 1 diabetes mellitus if added to conventional treatment?
    Roos AN; Meinders AE
    Neth J Med; 1989 Apr; 34(3-4):116-25. PubMed ID: 2657451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twenty-four hour blood glucose profiles during insulin and insulin plus aprotinin subcutaneous administration in type I diabetes.
    Lunetta M; Napoli E; Sudano L; Leonardi R; Mughini L
    Horm Metab Res; 1986 Mar; 18(3):182-4. PubMed ID: 2422103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin management of type I and type II diabetes in pregnancy.
    Hare JW
    Clin Obstet Gynecol; 1991 Sep; 34(3):494-504. PubMed ID: 1934701
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulin delivery by implantable pumps.
    Zoltobrocki M
    Horm Metab Res Suppl; 1992; 26():140-5. PubMed ID: 1490683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.